VideoHIVRSVCOVID-19OncologyHistorical Perspectives from Pasteur to Flexner: The Evolution of Serum to Monoclonal Antibody Therapy - Prof. FlexnerView Video
VideoHIVRSVCOVID-19OncologyMonoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Prof. AutranView Video
VideoHIVRSVCOVID-19OncologyMonoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Dr, CohenView Video
VideoHIVRSVCOVID-19OncologyMonoclonal Antibodies for Treatment in Autoimmune Diseases - Dr. ChanView Video
VideoHIVRSVCOVID-19OncologyMonoclonal Antibodies for Treatment in Hematologic Malignancies - Dr. MoskowitzView Video
VideoHIVRSVCOVID-19OncologyHow to Determine the Dosing (in Different Populations/Tissues) - Dr. CapparelliView Video
VideoHIVRSVCOVID-19OncologyMonoclonal Antibody Dosing in Pediatrics: Rational Basis and Examples - Dr. MeibohmView Video
VideoHIVRSVCOVID-19OncologyHow Will Technology Evolve: Modification of Antibodies - Dr. JuelgView Video
VideoHIVRSVCOVID-19OncologyHow Will Technology Evolve: Delivery Methods and Formulations - Dr. AppelView Video
VideoHIVRSVCOVID-19OncologyImplementing Monoclonal Antibodies for Treatment and Prevention in Resource-Limited Settings - How to Make Them Affordable - Dr. RipinView Video